BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8691554)

  • 1. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs.
    Radford MG; Holley KE; Grande JP; Larson TS; Wagoner RD; Donadio JV; McCarthy JT
    JAMA; 1996 Aug; 276(6):466-9. PubMed ID: 8691554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranous nephropathy and nonsteroidal anti-inflammatory agents.
    Nawaz FA; Larsen CP; Troxell ML
    Am J Kidney Dis; 2013 Nov; 62(5):1012-7. PubMed ID: 23773370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
    Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
    Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial thrombosis due to minimal change glomerulopathy secondary to nonsteroidal anti-inflammatory drugs.
    Huang JB; Yang WC; Yang AH; Lee PC; Lin CC
    Am J Med Sci; 2004 Jun; 327(6):358-61. PubMed ID: 15201652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and treatment of bucillamine-induced nephropathy.
    Hoshino J; Ubara Y; Hara S; Suwabe T; Sawa N; Tagami T; Katori H; Takemoto F; Hara S; Takaichi K
    Nephron Clin Pract; 2006; 104(1):c15-9. PubMed ID: 16685139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
    Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac.
    Révai T; Harmos G
    Wien Klin Wochenschr; 1999 Jul; 111(13):523-4. PubMed ID: 10444806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiopronin-induced membranous nephropathy: a case report.
    Zheng Z; Xue Y; Jia J; Wei L; Shang W; Lin S
    Ren Fail; 2014 Oct; 36(9):1455-60. PubMed ID: 25026975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous nephropathy: a 19 year prospective study in 51 patients.
    Hay NM; Bailey RR; Lynn KL; Robson RA
    N Z Med J; 1992 Dec; 105(947):489-91. PubMed ID: 1461605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single Chinese nephrology centre.
    Zhu P; Zhou FD; Wang SX; Zhao MH; Wang HY
    Nephrology (Carlton); 2015 Aug; 20(8):560-6. PubMed ID: 26086701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous nephropathy associated with the use of flurbiprofen.
    MacKay K
    Clin Nephrol; 1997 Apr; 47(4):279-80. PubMed ID: 9128803
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A; Mosconi L; Perna A; Mecca G; Bertani T; Garattini S; Remuzzi G
    N Engl J Med; 1993 Jul; 329(2):85-9. PubMed ID: 8510707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Membranous nephropathy - the most commonly diagnosed glomerulopathy in patients who underwent renal biopsy in the Department of Internal Medicine, Nephrology and Endocrinology St. Queen Jadwiga Clinical District Hospital No. 2 in Rzeszow].
    Kołodziej-Kłęk A; Gala-Błądzińska A; Okoń K; Sadowska A; Świder G
    Przegl Lek; 2017; 74(2):76-80. PubMed ID: 29694762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membranous glomerulonephritis].
    Polenaković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():18-25. PubMed ID: 9102898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism.
    Ravnskov U
    Br J Clin Pharmacol; 1999 Feb; 47(2):203-10. PubMed ID: 10190656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid.
    Funabiki K; Tomino Y; Shirato I; Yoshida M; Koide H
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):997-1001. PubMed ID: 1479738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A; Domínguez-Gil B; Carreño A; Hernández E; Morales E; Segura J; González E; Praga M
    Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.